{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:14:48Z","timestamp":1782274488185,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41401-019-0256-2","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T10:03:14Z","timestamp":1561716194000},"page":"286-292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening"],"prefix":"10.1038","volume":"41","author":[{"given":"Feng-cai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-ya","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-ping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen-hao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-yan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-hai","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"key":"256_CR1","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/384641a0","volume":"384","author":"AJ Bannister","year":"1996","unstructured":"Bannister AJ, Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature. 1996;384:641\u20133.","journal-title":"Nature"},{"key":"256_CR2","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.celrep.2018.07.041","volume":"24","author":"R Raisner","year":"2018","unstructured":"Raisner R, Kharbanda S, Jin L, Jeng E, Chan E, Merchant M, et al. Enhancer activity requires CBP\/P300 bromodomain-dependent histone H3K27 acetylation. Cell Rep. 2018;24:1722\u20139.","journal-title":"Cell Rep"},{"key":"256_CR3","doi-asserted-by":"publisher","first-page":"E1072","DOI":"10.1073\/pnas.1319122111","volume":"111","author":"C Das","year":"2014","unstructured":"Das C, Roy S, Namjoshi S, Malarkey CS, Jones DNM, Kutateladze TG, et al. Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation. Proc Natl Acad Sci U S A. 2014;111:E1072\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"256_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cell.2018.04.033","volume":"174","author":"BT Weinert","year":"2018","unstructured":"Weinert BT, Narita T, Satpathy S, Srinivasan B, Hansen BK, Scholz C, et al. Time-resolved analysis reveals rapid dynamics and broad scope of the CBP\/p300 acetylome. Cell. 2018;174:231\u201344 e12.","journal-title":"Cell"},{"key":"256_CR5","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1038\/sj.onc.1207118","volume":"23","author":"NG Iyer","year":"2004","unstructured":"Iyer NG, Ozdag H, Caldas C. P300\/CBP and cancer. Oncogene. 2004;23:4225\u201331.","journal-title":"Oncogene"},{"key":"256_CR6","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1021\/cr500452k","volume":"115","author":"BM Dancy","year":"2015","unstructured":"Dancy BM, Cole PA. Protein lysine acetylation by p300\/CBP. Chem Rev. 2015;115:2419\u201352.","journal-title":"Chem Rev"},{"key":"256_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.18632\/aging.100453","volume":"4","author":"DC Bedford","year":"2012","unstructured":"Bedford DC, Brindle PK. Is histone acetylation the most important physiological function for CBP andp300? Aging (Albany NY). 2012;4:247\u201355.","journal-title":"Aging (Albany NY)"},{"key":"256_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cbpa.2016.05.028","volume":"33","author":"NH Theodoulou","year":"2016","unstructured":"Theodoulou NH, Tomkinson NC, Prinjha RK, Humphreys PG. Clinical progress and pharmacology of small molecule bromodomain inhibitors. Curr Opin Chem Biol. 2016;33:58\u201366.","journal-title":"Curr Opin Chem Biol"},{"key":"256_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0168-9525(98)01438-3","volume":"14","author":"RH Giles","year":"1998","unstructured":"Giles RH, Peters DJ, Breuning MH. Conjunction dysfunction: CBP\/p300 in human disease. Trends Genet. 1998;14:178\u201383.","journal-title":"Trends Genet"},{"key":"256_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrd4286","volume":"13","author":"P Filippakopoulos","year":"2014","unstructured":"Filippakopoulos P, Knapp S. Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Discov. 2014;13:337\u201356.","journal-title":"Nat Rev Drug Disco"},{"key":"256_CR11","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1021\/acs.jmedchem.5b00171","volume":"59","author":"M Xu","year":"2016","unstructured":"Xu M, Unzue A, Dong J, Spiliotopoulos D, Nevado C, Caflisch A. Discovery of CREBBP bromodomain inhibitors by high-throughput docking and hit optimization guided by molecular dynamics. J Med Chem. 2016;59:1340\u20139.","journal-title":"J Med Chem"},{"key":"256_CR12","doi-asserted-by":"publisher","first-page":"e19432","DOI":"10.7554\/eLife.19432","volume":"5","author":"AR Conery","year":"2016","unstructured":"Conery AR, Centore RC, Neiss A, Keller PJ, Joshi S, Spillane KL, et al. Bromodomain inhibition of the transcriptional coactivators CBP\/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma. Elife. 2016;5:e19432.","journal-title":"Elife"},{"key":"256_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/sj.embor.embor821","volume":"4","author":"J Vervoorts","year":"2003","unstructured":"Vervoorts J, Luscher-Firzlaff JM, Rottmann S, Lilischkis R, Walsemann G, Dohmann K, et al. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 2003;4:484\u201390.","journal-title":"EMBO Rep"},{"key":"256_CR14","doi-asserted-by":"publisher","first-page":"10220","DOI":"10.1128\/MCB.25.23.10220-10234.2005","volume":"25","author":"F Faiola","year":"2005","unstructured":"Faiola F, Liu XH, Lo SY, Pan SQ, Zhang KL, Lymar E, et al. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription. Mol Cell Biol. 2005;25:10220\u201334.","journal-title":"Mol Cell Biol"},{"key":"256_CR15","doi-asserted-by":"publisher","first-page":"10549","DOI":"10.1021\/acs.jmedchem.6b01022","volume":"59","author":"TD Crawford","year":"2016","unstructured":"Crawford TD, Romero FA, Lai KW, Tsui V, Taylor AM, de Leon Boenig G, et al. Discovery of a potent and selective in vivo probe (GNE-272) for the bromodomains of CBP\/EP300. J Med Chem. 2016;59:10549\u201363.","journal-title":"J Med Chem"},{"key":"256_CR16","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/j.bmcl.2017.04.001","volume":"27","author":"D Spiliotopoulos","year":"2017","unstructured":"Spiliotopoulos D, Zhu J, Wamhoff EC, Deerain N, Marchand JR, Aretz J, et al. Virtual screen to NMR (VS2NMR): Discovery of fragment hits for the CBP bromodomain. Bioorg Med Chem Lett. 2017;27:2472\u20138.","journal-title":"Bioorg Med Chem Lett"},{"key":"256_CR17","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1158\/0008-5472.CAN-17-0314","volume":"77","author":"L Jin","year":"2017","unstructured":"Jin L, Garcia J, Chan E, de la Cruz C, Segal E, Merchant M, et al. Therapeutic targeting of the CBP\/p300 bromodomain blocks the growth of castration-resistant prostate cancer. Cancer Res. 2017;77:5564\u201375.","journal-title":"Cancer Res"},{"key":"256_CR18","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1158\/0008-5472.CAN-15-0236","volume":"75","author":"S Picaud","year":"2015","unstructured":"Picaud S, Fedorov O, Thanasopoulou A, Leonards K, Jones K, Meier J, et al. Generation of a selective small molecule inhibitor of the CBP\/p300 bromodomain for leukemia therapy. Cancer Res. 2015;75:5106\u201319.","journal-title":"Cancer Res"},{"key":"256_CR19","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.chembiol.2015.10.013","volume":"22","author":"EL Chekler","year":"2015","unstructured":"Chekler EL, Pellegrino JA, Lanz TA, Denny RA, Flick AC, Coe J, et al. Transcriptional profiling of a selective CREB binding protein bromodomain inhibitor highlights therapeutic opportunities. Chem Biol. 2015;22:1588\u201396.","journal-title":"Chem Biol"},{"key":"256_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.chembiol.2005.10.014","volume":"13","author":"Sachchidanand","year":"2006","unstructured":"Sachchidanand, Resnick-Silverman L, Yan S, Mutjaba S, Liu WJ, Zeng L, et al. Target structure-based discovery of small molecules that block human p53 and CREB binding protein association. Chem Biol. 2006;13:81\u201390.","journal-title":"Chem Biol"},{"key":"256_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ejmech.2018.01.087","volume":"147","author":"Q Xiang","year":"2018","unstructured":"Xiang Q, Wang C, Zhang Y, Xue X, Song M, Zhang C, et al. Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP\/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer. Eur J Med Chem. 2018;147:238\u201352.","journal-title":"Eur J Med Chem"},{"key":"256_CR22","doi-asserted-by":"publisher","first-page":"9308","DOI":"10.1021\/ja412434f","volume":"136","author":"DA Hay","year":"2014","unstructured":"Hay DA, Fedorov O, Martin S, Singleton DC, Tallant C, Wells C, et al. Discovery and optimization of small-molecule ligands for the CBP\/p300 bromodomains. J Am Chem Soc. 2014;136:9308\u201319.","journal-title":"J Am Chem Soc"},{"key":"256_CR23","doi-asserted-by":"publisher","first-page":"10151","DOI":"10.1021\/acs.jmedchem.7b01372","volume":"60","author":"SM Bronner","year":"2017","unstructured":"Bronner SM, Murray J, Romero FA, Lai KW, Tsui V, Cyr P, et al. A unique approach to design potent and selective cyclic adenosine monophosphate response element binding protein, binding protein (CBP) inhibitors. J Med Chem. 2017;60:10151\u201371.","journal-title":"J Med Chem"},{"key":"256_CR24","doi-asserted-by":"publisher","first-page":"8889","DOI":"10.1021\/acs.jmedchem.6b00774","volume":"59","author":"TA Popp","year":"2016","unstructured":"Popp TA, Tallant C, Rogers C, Fedorov O, Brennan PE, Muller S, et al. Development of selective CBP\/P300 benzoxazepine bromodomain inhibitors. J Med Chem. 2016;59:8889\u2013912.","journal-title":"J Med Chem"},{"key":"256_CR25","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1021\/acs.jmedchem.5b01514","volume":"59","author":"FA Romero","year":"2016","unstructured":"Romero FA, Taylor AM, Crawford TD, Tsui V, Cote A, Magnuson S. Disrupting acetyl-lysine recognition: Progress in the development of bromodomain inhibitors. J Med Chem. 2016;59:1271\u201398.","journal-title":"J Med Chem"},{"key":"256_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1039\/C2MD20189E","volume":"4","author":"D Hay","year":"2013","unstructured":"Hay D, Fedorov O, Filippakopoulos P, Martin S, Philpott M, Picaud S, et al. The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains. Medchemcomm. 2013;4:140\u20134.","journal-title":"Medchemcomm"},{"key":"256_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cbpa.2018.06.005","volume":"45","author":"ME Breen","year":"2018","unstructured":"Breen ME, Mapp AK. Modulating the masters: chemical tools to dissect CBP and p300 function. Curr Opin Chem Biol. 2018;45:195\u2013203.","journal-title":"Curr Opin Chem Biol"},{"key":"256_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang JH, Chung TDY, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen. 1999;4:67\u201373.","journal-title":"J Biomol Screen"},{"key":"256_CR29","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004;47:1739\u201349.","journal-title":"J Med Chem"},{"key":"256_CR30","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/aps.2017.188","volume":"39","author":"T Lu","year":"2018","unstructured":"Lu T, Hu JC, Lu WC, Han J, Ding H, Jiang H, et al. Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay. Acta Pharmacol Sin. 2018;39:1544\u201352.","journal-title":"Acta Pharm Sin"},{"key":"256_CR31","doi-asserted-by":"publisher","first-page":"9028","DOI":"10.1021\/jm501134e","volume":"57","author":"S Chen","year":"2014","unstructured":"Chen S, Wang Y, Zhou W, Li S, Peng J, Shi Z, et al. Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening. J Med Chem. 2014;57:9028\u201341.","journal-title":"J Med Chem"},{"key":"256_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/nrd3368","volume":"10","author":"R Macarron","year":"2011","unstructured":"Macarron R, Banks MN, Bojanic D, Burns DJ, Cirovic DA, Garyantes T, et al. Impact of high-throughput screening in biomedical research. Nat Rev Drug Discov. 2011;10:188\u201395.","journal-title":"Nat Rev Drug Disco"},{"key":"256_CR33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.str.2013.10.021","volume":"22","author":"AN Plotnikov","year":"2014","unstructured":"Plotnikov AN, Yang S, Zhou TJ, Rusinova E, Frasca A, Zhou MM. Structural insights into acetylated-histone H4 recognition by the bromodomain-PHD finger module of human transcriptional coactivator CBP. Structure. 2014;22:353\u201360.","journal-title":"Structure"},{"key":"256_CR34","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.str.2008.01.010","volume":"16","author":"L Zeng","year":"2008","unstructured":"Zeng L, Zhang Q, Gerona-Navarro G, Moshkina N, Zhou MM. Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP\/p300. Structure. 2008;16:643\u201352.","journal-title":"Structure"},{"key":"256_CR35","doi-asserted-by":"publisher","first-page":"12476","DOI":"10.1002\/anie.201705516","volume":"56","author":"M Hugle","year":"2017","unstructured":"Hugle M, Lucas X, Ostrovskyi D, Regenass P, Gerhardt S, Einsle O, et al. Beyond the BET family: Targeting CBP\/p300 with 4-acyl pyrroles. Angew Chem Int Ed Engl. 2017;56:12476\u201380.","journal-title":"Angew Chem Int Ed Engl"},{"key":"256_CR36","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1101\/gad.14.13.1553","volume":"14","author":"RH Goodman","year":"2000","unstructured":"Goodman RH, Smolik S. CBP\/p300 in cell growth, transformation, and development. Genes Dev. 2000;14:1553\u201377.","journal-title":"Genes Dev"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0256-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0256-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0256-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:04Z","timestamp":1684616524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-019-0256-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["256"],"URL":"https:\/\/doi.org\/10.1038\/s41401-019-0256-2","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,28]]},"assertion":[{"value":"18 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}